Organovo Holdings Inc. (NASDAQ:ONVO) has received a consensus broker rating score of 1.00 (Strong Buy) from the two brokers that provide coverage for the company, Zacks Investment Research reports. Two research analysts have rated the stock with a strong buy rating.

Analysts have set a 1 year consensus price objective of $4.75 for the company and are anticipating that the company will post ($0.11) earnings per share for the current quarter, according to Zacks. Zacks has also given Organovo Holdings an industry rank of 92 out of 265 based on the ratings given to related companies.

Several research firms have issued reports on ONVO. Zacks Investment Research raised Organovo Holdings from a “sell” rating to a “hold” rating and set a $5.25 target price for the company in a research note on Wednesday, August 10th. Jefferies Group reissued a “buy” rating and set a $4.50 target price (up previously from $4.00) on shares of Organovo Holdings in a research note on Thursday, July 21st.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/20/organovo-holdings-inc-nasdaqonvo-given-4-75-average-target-price-by-analysts.html

In other news, EVP Eric David sold 20,000 shares of the firm’s stock in a transaction on Friday, August 5th. The stock was sold at an average price of $4.55, for a total transaction of $91,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 12.50% of the company’s stock.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in ONVO. Lehman Financial Resources Inc. raised its position in Organovo Holdings by 1.2% in the second quarter. Lehman Financial Resources Inc. now owns 131,400 shares of the company’s stock valued at $488,000 after buying an additional 1,500 shares in the last quarter. Schwab Charles Investment Management Inc. raised its position in Organovo Holdings by 1.4% in the second quarter. Schwab Charles Investment Management Inc. now owns 264,596 shares of the company’s stock valued at $985,000 after buying an additional 3,654 shares in the last quarter. Cowen Group Inc. raised its position in Organovo Holdings by 8.6% in the second quarter. Cowen Group Inc. now owns 63,000 shares of the company’s stock valued at $234,000 after buying an additional 5,000 shares in the last quarter. BlackRock Advisors LLC raised its position in Organovo Holdings by 20.3% in the second quarter. BlackRock Advisors LLC now owns 39,509 shares of the company’s stock valued at $147,000 after buying an additional 6,670 shares in the last quarter. Finally, BlackRock Investment Management LLC raised its position in Organovo Holdings by 4.3% in the second quarter. BlackRock Investment Management LLC now owns 337,533 shares of the company’s stock valued at $1,256,000 after buying an additional 14,070 shares in the last quarter. Institutional investors and hedge funds own 19.11% of the company’s stock.

Shares of Organovo Holdings (NASDAQ:ONVO) traded down 1.99% on Tuesday, reaching $3.94. The company had a trading volume of 426,712 shares. The company’s market capitalization is $365.06 million. The company has a 50 day moving average of $4.17 and a 200-day moving average of $3.24. Organovo Holdings has a 52 week low of $1.60 and a 52 week high of $4.99.

Organovo Holdings (NASDAQ:ONVO) last posted its earnings results on Thursday, August 4th. The company reported ($0.09) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.10) by $0.01. Organovo Holdings had a negative return on equity of 59.27% and a negative net margin of 1,878.68%. Analysts predict that Organovo Holdings will post ($0.42) earnings per share for the current fiscal year.

Organovo Holdings Company Profile

5 Day Chart for NASDAQ:ONVO

Get a free copy of the Zacks research report on Organovo Holdings (ONVO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Organovo Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organovo Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.